Pharmaceutical Business review

iCAD launches SecondLook digital CAD technology outside of US

iCAD has received CE mark approval to market and sell its customized solution with Planmed Nuance mammography systems and units have been placed at Terveystalo Breast Cancer Screening Center in Helsinki, Finland.

Ken Ferry, president and CEO of iCAD, said: “Our partnership with Planmed marks an important step in iCAD’s mammography strategy. Coupling our SecondLook CAD technology with Planmed’s Nuance FFDM system is a key element in our overall goal to increase the use of iCAD’s systems in markets around the globe to better enable clinicians to identify breast cancer earlier.”